Not Yet Recruiting
Glofitamab Combined With Selinexor in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
NCT07669194
- Conditions
- Diffuse Large B-Cell Lymphoma (DLBCL), Disease Attributes, Hemic and Lymphatic Diseases, +13 more
- Locations
-
- Second Affiliated Hospital, School of Medicine, Zhejiang University Hangzhou, Zhejiang, China